Discovery and development of statins different pharmacophore structure were found. This structure-based virtual screening procedure is considered promising for rational quest and optimization of potential novel HGMR inhibitors. Discovery and development of statins The discovery of HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors, called statins, was a breakthrough in the prevention of hypercholesterolemia and related diseases. Hypercholesterolemia is considered to be one of the major risk factors for atherosclerosis which often leads to cardiovascular, cerebrovascular and peripheral vascular diseases. The statins inhibit cholesterol synthesis in the body and that leads to reduction in blood cholesterol levels, which is thought to reduce the risk of atherosclerosis and diseases caused
We Are Drugs to finish them after the band finished touring to support "Dopamine"—he would want to release. Several months later, Jenkins began discussing plans for a new EP release in mid-2016. Contrary to the band's previous few albums—"Out of the Vein" (2003), "Ursa Major" (2009), and "Dopamine" (2015), which were recorded over the course of four to six years—the band was limited to only one week in a studio in Texas in early 2016 to record "We Are Drugs". Jenkins stated that the success of "Dopamine" finally allowed him to stop obsessing over perfecting lyrics, something he had done in the past.